Trial intelligence / Profile preview

Reduning Injection for Influenza in Children

NCT04183725Phase 4Unknown

Sponsor
China Academy of Chinese Medical Sciences
Start
Dec 2019
Primary completion
Jun 2021
Modality
Botanical Extract
01

Overview

Phase 4, randomised, double-blind trial of Reduning in influenza (2 arms), sponsored by China Academy of Chinese Medical Sciences. Primary endpoint: Time of temperature recovery at 5 days. Status: unknown.

02

Drugs

Reduning
03

Conditions

influenza

Beyond the preview

Go deeper on NCT04183725.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04183725.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call